Filing Details
- Accession Number:
- 0001325812-15-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-18 16:38:37
- Reporting Period:
- 2015-06-16
- Filing Date:
- 2015-06-18
- Accepted Time:
- 2015-06-18 16:38:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458494 | Akshay Vaishnaw | 300 Third Street Cambridge MA 02142 | Evp, R&D, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-16 | 6,250 | $9.30 | 6,250 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-06-16 | 2,500 | $7.10 | 8,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-16 | 3,933 | $128.10 | 4,817 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-16 | 2,667 | $128.79 | 2,150 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-16 | 1,800 | $130.06 | 350 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-16 | 350 | $131.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-06-16 | 2,500 | $0.00 | 2,500 | $7.10 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-06-16 | 6,250 | $0.00 | 6,250 | $9.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2021-11-30 | No | 4 | M | Direct | |
0 | 2021-06-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 103 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2013
- Sale prices ranged from $127.49 to $128.46.
- Sale prices ranged from $128.49 to $129.38.
- Sale prices ranged from $129.55 to $130.50.
- Sale prices ranged from $130.57 to $131.22.
- The reporting person owns 103 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.